How it works
It carries alpha-MSH's anti-inflammatory activity without the pigmentation effects of the full hormone, appearing to dampen inflammatory signaling inside cells — studied especially in gut inflammation models.
The evidence
Evidence is largely preclinical (cell and animal models of inflammation, including colitis). Human clinical data is limited, so its real-world benefit and dosing are unproven.
Safety
As a mostly-preclinical compound, human safety isn't well characterized. It's an unapproved research chemical; both effects and vial contents are open questions.
FAQ
Both derive from alpha-MSH, but KPV is a small fragment aimed at anti-inflammatory effects, without the tanning/central actions.
Limited — most evidence is preclinical.
Sources
This profile summarizes the following. Follow the links to read the originals — and remember that summaries age, so check for newer information.
Inclusion here is not endorsement of any source's claims; several are cited so you can compare how different outlets characterize the same evidence.
Reviewed by Theo — part of the PepConnection crew.